Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

NIH awards research grant for development of Cel-Sci's AIDS vaccine

Oct. 30, 1997

Procept completes phase I testing with PRO-2000 gel

Oct. 22, 1997

Aronex receives grants for development of HIV integrase inhibitor

Oct. 22, 1997

Positive results obtained with Theratechnologies' AIDS gene therapy

Oct. 21, 1997

Promising preliminary phase II data reported for VX-478/141W94

Oct. 20, 1997

HIV-infected T-cells and macrophages efficiently killed by new T-cell gene therapy

Oct. 16, 1997

PNU-140690: a novel HIV protease inhibitor in clinical testing at P&U

Oct. 14, 1997

Combined pharmacological/genetic strategy for HIV shows promise

Oct. 13, 1997

NIH approves study of marijuana in HIV-infected patients

Oct. 13, 1997

Boehringer Ingelheim presents compounds active against mutant HIV-1 RT

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...